Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Paper of the Day - Combination of BP drugs cuts death risk in diabetes

Giving a fixed dose combination antihypertensive to everyone with Type 2 diabetes- regardless of blood pressure- cuts the risk of cardiovascular death by 18% according to a study of over 110,000 patients.

Patients with a range of blood pressures at baseline were randomised to receive a fixed dose of the ACE inhibitor perindopril and the thiazide diuretic indapamide or placebo.

After an average 4.3 years follow up, blood pressures in the intervention group were 5.6/2.2 mmHg lower than the placebo arm.

The relative risk of death from cardiovascular disease in the intervention group was reduced by 18% and death from any cause was down by 14%.

Such treatment should be considered routinely for anyone with type 2 diabetes say the authors.

The Lancet online September 2.

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say